Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5α-reductase 2 deficiency

Ze'ev Hochberg*, Ralph Chayen, Nira Reiss, Zipora Falik, Amnon Makler, Mariana Munichor, Amicur Farkas, Haya Goldfarb, Nissim Ohana, Olaf Hiort

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The present report describes a cluster of eight patients with male pseudohermaphroditism from a large pedigree with steroid 5α-reductase 2 deficiency (5αRD), who reside in Southern Lebanon. They were born with unambiguous female external genitalia and reared as girls until puberty, when masculinization occurred, followed by a change of gender role. Semen analysis and testicular histology revealed maturation arrest of spermatogenesis, with low sperm count and motility. Determination of urinary 5α- and 5β-reduced adrenal steroids enabled us to diagnose the disease in a male patient with the full-blown clinical syndrome, in another male patient who had undergone bilateral orchidectomy, and in three female individuals with the biochemical derangement. The female patients were unique in this family with respect to their low degree of virilization, but had normal menstrual cycles. Molecular genetic studies were performed on DNA extracted from peripheral leukocytes and from cultured genital skin fibroblasts. The coding sequence of the 5αR2 gene (SRD5A2) was studied by exon-specific PCR, single strand conformation polymorphism, and direct sequencing. A homozygous point mutation was identified in exon 1, leading to a thymidine for adenine substitution, predicting amino acid substitution of leucine for glutamine at position 55.

OriginalspracheEnglisch
ZeitschriftJournal of Clinical Endocrinology and Metabolism
Jahrgang81
Ausgabenummer8
Seiten (von - bis)2821-2827
Seitenumfang7
ISSN0021-972X
DOIs
PublikationsstatusVeröffentlicht - 1996

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality
  3. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5α-reductase 2 deficiency“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren